Search | Page 2 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Outcome of Allogeneic Stem Cell Transplantation for Patients Transformed to MDS or Leukemia from Severe Aplastic Anemia. A report by the MDS subcommittee of the chronic malignancies working party (CMWP) and the severe aplastic anemia working party (WPSAA)

    ... Journal Title:  Biol Blood Marrow Transplant Primary Author:  ... remission than in patients with refractory disease. Allogeneic HSCT leads to prolonged survival in close to half of the patients ...

    Research Article last updated 07/20/2018 - 5:15pm.

  2. Second allogeneic hematopoietic stem cell transplantation in children with severe aplastic anemia

    ... Journal Title:  Bone Marrow Transplant Primary Author:  ... anemia (SAA) who received a second hematopoietic stem cell transplantation (HSCT) was retrospectively analyzed using the ...

    Research Article last updated 07/20/2018 - 5:15pm.

  3. Response to pre-transplant hypomethylating agents influences the outcome of allogeneic hematopoietic stem cell transplantation in adults with myelodysplastic syndromes

    ... The present study describes a retrospective analysis on the transplant outcome of 56 consecutive myelodysplastic syndrome (MDS) patients ...

    Research Article last updated 07/20/2018 - 5:14pm.

  4. Comparison between Matched Related and Alternative Donors of Allogeneic Hematopoietic Stem Cells Transplanted into Adult Patients with Acquired Aplastic Anemia: Multivariate and Propensity Score-Matched Analysis.

    ... adult acquired aplastic anemia (AA) who underwent allogeneic hematopoietic stem cell transplantation (alloHSCT) from matched related donors (MRDs), and ...

    Research Article last updated 07/20/2018 - 5:14pm.

  5. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogenei

    ... has become the major cause of treatment failure after allogeneic stem cell transplantation. Outcome of patients with clinical relapse after ...

    Research Article last updated 07/20/2018 - 5:14pm.

  6. Novel approaches for myelodysplastic syndromes: beyond hypomethylating agents.

    ... index may help select appropriate patients for allogeneic stem cell transplant . A variety of promising new agents are under ...

    Research Article last updated 07/20/2018 - 5:14pm.

  7. Hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria: long-term results of a retrospective study on behalf of the Gruppo Italiano Trapianto Midollo Osseo (GITMO).

    ... is an acquired clonal disorder of the hemopoietic stem cells for which the only curative treatment is allogeneic hematopoietic stem cell transplantation. DESIGN AND METHODS: ...

    Research Article last updated 07/20/2018 - 5:14pm.

  8. Myelodysplastic syndrome hematopoietic stem cell

    ... syndromes (MDSs) are clonal hematopoietic stem cell (HSC) malignancies that are characterized by ineffective hematopoiesis ... can actually alter the natural history of this disease. Allogeneic stem-cell transplantation for high-risk MDS is becoming the only ...

    Research Article last updated 07/20/2018 - 5:14pm.

  9. Optimizing stem cell transplantation in myelodysplastic syndromes: unresolved questions.

    ... PURPOSE OF REVIEW: Allogeneic hematopoietic stem cell transplantation (HCT) is the only curative therapy for ...

    Research Article last updated 07/20/2018 - 5:14pm.

  10. 5-Azacytidine in myelodysplastic syndromes: a clinical practice guideline.

    ... blasts ) who cannot proceed immediately to allogeneic stem cell transplant . 5-Aza is not recommended as first line therapy with ...

    Research Article last updated 07/20/2018 - 5:14pm.